SE338401B - - Google Patents

Info

Publication number
SE338401B
SE338401B SE00293/67A SE29367A SE338401B SE 338401 B SE338401 B SE 338401B SE 00293/67 A SE00293/67 A SE 00293/67A SE 29367 A SE29367 A SE 29367A SE 338401 B SE338401 B SE 338401B
Authority
SE
Sweden
Application number
SE00293/67A
Inventor
R Barry
M Weiss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE338401B publication Critical patent/SE338401B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE00293/67A 1966-01-13 1967-01-09 SE338401B (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52036966A 1966-01-13 1966-01-13

Publications (1)

Publication Number Publication Date
SE338401B true SE338401B (en, 2012) 1971-09-06

Family

ID=24072303

Family Applications (1)

Application Number Title Priority Date Filing Date
SE00293/67A SE338401B (en, 2012) 1966-01-13 1967-01-09

Country Status (10)

Country Link
US (1) US3427379A (en, 2012)
BE (1) BE692250A (en, 2012)
DE (1) DE1617515A1 (en, 2012)
DK (1) DK118301B (en, 2012)
ES (1) ES335565A1 (en, 2012)
FR (1) FR6250M (en, 2012)
GB (1) GB1111173A (en, 2012)
IL (1) IL27056A (en, 2012)
NL (1) NL6700549A (en, 2012)
SE (1) SE338401B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903284A (en) * 1971-10-06 1975-09-02 Denson Fred L Composition containing iminoethanophenanthrene derivatives and method of use
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4971798A (en) * 1989-11-30 1990-11-20 Miles Inc. Hard confections containing hydrogenated isomaltulose and medicinally active ingredient
CH685978A5 (fr) * 1991-01-30 1995-11-30 Wellcome Found Comprimes dispersables dans l'eau.
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20050238695A1 (en) * 2004-04-27 2005-10-27 Atma Chaudhari Lozenge for delivery of dextromethorphan
US8668902B2 (en) * 2006-06-08 2014-03-11 Vapor Shield, Inc. Composition with activated carbon in oral treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123528A (en) * 1964-03-03 New therapeutic compositions
US2841528A (en) * 1954-09-21 1958-07-01 Collett & Co As Method of making fused tablets
US2963404A (en) * 1958-09-05 1960-12-06 Pfizer & Co C Tannate candy making, and product
US3012893A (en) * 1959-01-06 1961-12-12 Gen Foods Corp Gasified confection and method of making the same
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3248290A (en) * 1962-08-09 1966-04-26 Hoffmann La Roche Antitussive compositions
US3282789A (en) * 1963-05-17 1966-11-01 Neisler Lab Inc Stable liquid colloidal tannate compositions
US3341414A (en) * 1964-08-27 1967-09-12 Merck & Co Inc N-cyclohexylsulfamate solubilized medication

Also Published As

Publication number Publication date
NL6700549A (en, 2012) 1967-07-14
FR6250M (en, 2012) 1968-08-19
DE1617515A1 (de) 1971-03-18
IL27056A (en) 1970-07-19
BE692250A (en, 2012) 1967-07-06
DK118301B (da) 1970-08-03
GB1111173A (en) 1968-04-24
ES335565A1 (es) 1968-03-16
US3427379A (en) 1969-02-11

Similar Documents

Publication Publication Date Title
AT281852B (en, 2012)
AU5917865A (en, 2012)
AU428063B2 (en, 2012)
AU424443B2 (en, 2012)
AU414526B2 (en, 2012)
AU433222B2 (en, 2012)
AU421822B2 (en, 2012)
AU417216B2 (en, 2012)
AU415165B1 (en, 2012)
AU1111066A (en, 2012)
AU6703465A (en, 2012)
AU612166A (en, 2012)
AU1144366A (en, 2012)
AU218666A (en, 2012)
AU5895065A (en, 2012)
BE447356A (en, 2012)
AU411645B2 (en, 2012)
BE675173A (en, 2012)
AU2390066A (en, 2012)
AU407778B2 (en, 2012)
BE675139A (en, 2012)
AU415780B2 (en, 2012)
AU6852465A (en, 2012)
AU855865A (en, 2012)
AU92366A (en, 2012)